Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Bibliographic Details
Main Authors: Ilag, L. L., Deeg, M. A., Costigan, T., Hollander, P., Blevins, T. C., Edelman, S. V., Konrad, R. J., Ortmann, R. A., Pollom, R. K., Huster, W. J., Zielonka, J. S., Prince, M. J.
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737399/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737399/

Similar Items